Old Web
English
Sign In
Acemap
>
authorDetail
>
E. E. Voest
E. E. Voest
Medicine
Internal medicine
Immunology
Iron Chelating Agents
Cardiology
5
Papers
124
Citations
0.02
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
[Gene-expression analysis using DNA microarrays].
2002
Nederlands Tijdschrift voor Geneeskunde
G. B. Braam
Hans A.R. Bluyssen
E. E. Voest
H.A. Koomans
Show All
Source
Cite
Save
Citations (2)
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer
1997
British Journal of Cancer
C. J. A. Punt
E. E. Voest
E. Tueni
A. van Oosterom
A.P.C.M. Backx
P.H.M. de Mulder
B. Hecquet
C Lucas
Béatrice Gerard
Harry Bleiberg
Show All
Source
Cite
Save
Citations (14)
Molecular and biological factors in the prognosis of non-small cell lung cancer
1995
European Respiratory Journal
S. D. J. M. Kanters
J-W.J. Lammers
E. E. Voest
Show All
Source
Cite
Save
Citations (46)
Iron-Chelating Agents in Non-Iron Overload Conditions
1994
Annals of Internal Medicine
E. E. Voest
G. Vreugdenhil
J. J. M. Marx
Show All
Source
Cite
Save
Citations (58)
Iron Chelating Agents Are Not Useful in Treating Atherosclerosis
1994
Annals of Internal Medicine
J. J. M. Marx
G. Vreugdenhil
E. E. Voest
Show All
Source
Cite
Save
Citations (4)
1